Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 302

1.
2.

The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.

Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C, Mavrikakis M.

Ophthalmology. 2003 Jul;110(7):1321-6.

PMID:
12867385
3.

Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.

Aylward JM.

J Am Optom Assoc. 1993 Nov;64(11):787-97. Review.

PMID:
8120333
4.

Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.

Wolfe F, Marmor MF.

Arthritis Care Res (Hoboken). 2010 Jun;62(6):775-84. doi: 10.1002/acr.20133.

5.

Long-term effectiveness of antimalarial drugs in rheumatic diseases.

Aviña-Zubieta JA, Galindo-Rodriguez G, Newman S, Suarez-Almazor ME, Russell AS.

Ann Rheum Dis. 1998 Oct;57(10):582-7.

6.
7.

Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity.

Finbloom DS, Silver K, Newsome DA, Gunkel R.

J Rheumatol. 1985 Aug;12(4):692-4.

PMID:
4057189
8.

An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.

Easterbrook M.

J Rheumatol. 1999 Sep;26(9):1866-8. No abstract available.

PMID:
10493662
9.

Discontinuation of antimalarial drugs in systemic lupus erythematosus.

Wang C, Fortin PR, Li Y, Panaritis T, Gans M, Esdaile JM.

J Rheumatol. 1999 Apr;26(4):808-15.

PMID:
10229401
10.

Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis.

Munster T, Gibbs JP, Shen D, Baethge BA, Botstein GR, Caldwell J, Dietz F, Ettlinger R, Golden HE, Lindsley H, McLaughlin GE, Moreland LW, Roberts WN, Rooney TW, Rothschild B, Sack M, Sebba AI, Weisman M, Welch KE, Yocum D, Furst DE.

Arthritis Rheum. 2002 Jun;46(6):1460-9.

11.

Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Rainsford KD, Parke AL, Clifford-Rashotte M, Kean WF.

Inflammopharmacology. 2015 Oct;23(5):231-69. doi: 10.1007/s10787-015-0239-y. Epub 2015 Aug 6. Review.

PMID:
26246395
12.

Chloroquine and hydroxychloroquine retinopathy-related risk factors in a Turkish cohort.

Yaylali SA, Sadigov F, Erbil H, Ekinci A, Akcakaya AA.

Int Ophthalmol. 2013 Dec;33(6):627-34. doi: 10.1007/s10792-013-9748-0. Epub 2013 Mar 2.

PMID:
23456514
13.

Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice.

Levy GD, Munz SJ, Paschal J, Cohen HB, Pince KJ, Peterson T.

Arthritis Rheum. 1997 Aug;40(8):1482-6.

PMID:
9259429
14.

Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.

Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF; American Academy of Ophthalmology.

Ophthalmology. 2011 Feb;118(2):415-22. doi: 10.1016/j.ophtha.2010.11.017.

PMID:
21292109
15.

Hydrochloroquine retinopathy: characteristic presentation with review of screening.

Stelton CR, Connors DB, Walia SS, Walia HS.

Clin Rheumatol. 2013 Jun;32(6):895-8. doi: 10.1007/s10067-013-2226-2. Epub 2013 Mar 21. Review.

PMID:
23515601
16.

Missing the bull's eye.

Gilbert ME, Savino PJ.

Surv Ophthalmol. 2007 Jul-Aug;52(4):440-2.

PMID:
17574068
17.

Preferential Hyperacuity Perimetry to detect hydroxychloroquine retinal toxicity.

Anderson C, Pahk P, Blaha GR, Spindel GP, Alster Y, Rafaeli O, Marx JL.

Retina. 2009 Sep;29(8):1188-92. doi: 10.1097/IAE.0b013e3181a3b8d4.

PMID:
19491724
18.

Antimalarial therapy in SLE.

Lanham JG, Hughes GR.

Clin Rheum Dis. 1982 Apr;8(1):279-98. Review. No abstract available.

PMID:
6749400
19.

Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature.

Nord JE, Shah PK, Rinaldi RZ, Weisman MH.

Semin Arthritis Rheum. 2004 Apr;33(5):336-51. Review.

PMID:
15079764
20.

Should patients on hydroxychloroquine have their eyes examined regularly?

Shipley M, Silman A.

Br J Rheumatol. 1997 May;36(5):514-5. No abstract available.

PMID:
9189050

Supplemental Content

Support Center